QUINGARD Trademark

Trademark Overview


On Tuesday, November 5, 2013, a trademark application was filed for QUINGARD with the United States Patent and Trademark Office. The USPTO has given the QUINGARD trademark a serial number of 79141164. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, November 5, 2023. This trademark is owned by Novartis AG. The QUINGARD trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
quingard

General Information


Serial Number79141164
Word MarkQUINGARD
Filing DateTuesday, November 5, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, November 5, 2023
Registration Number4535434
Registration DateTuesday, May 27, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, January 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 14, 2014APPLICATION FILING RECEIPT MAILED
Friday, January 3, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, February 19, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, June 26, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, January 29, 2014ASSIGNED TO EXAMINER
Monday, February 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2014NOTICE OF PUBLICATION
Wednesday, February 19, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 7, 2014NOTIFICATION PROCESSED BY IB
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 27, 2014REGISTERED-PRINCIPAL REGISTER
Friday, February 26, 2021CANCELLED SECTION 71
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 11, 2014FINAL DISPOSITION PROCESSED
Friday, July 11, 2014FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 31, 2014NOTIFICATION PROCESSED BY IB
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Tuesday, March 8, 2022INVALIDATION PROCESSED
Monday, May 27, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, May 27, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, April 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, March 8, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords


quingard human vaccines